RecruitingNCT06756542

Evaluating the Use of Artificial Intelligence to Improve Family Conversations for Intensive Care Patients and Their Families

Utilizing Large Language Models to Augment Family Conversations in the Intensive Care Unit


Sponsor

Davy van de Sande

Enrollment

40 participants

Start Date

Jan 14, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study looks at how artificial intelligence (AI), like generative pre-trained transformer (GPT-4), can help doctors in the intensive care unit (ICU) save time and improve communication with families. Right now, doctors spend a lot of time writing notes after family conversations, which takes time away from patient care. The investigators are testing whether AI can create accurate and easy-to-understand summaries of these conversations, making it quicker for doctors to document and clearer for families to understand. ICU doctors and adult family members of patients will take part in this study, with their full consent. The goal is to see if this new technology can make life easier for doctors while helping families better understand medical information.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Informed-consent is signed by all participating family members during the conversation.
  • Informed-consent is signed by the ICU healthcare professionals.
  • The patient of the family must be admitted to the adult ICU.
  • All participating family members must be 18 years or older.
  • The family conversation must be in Dutch.

Exclusion Criteria2

  • Trained to interpret medical jargon and/or intensive care terminology specifically
  • Difficulty reading and/or writing in the Dutch language

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Erasmus University Medical Center

Rotterdam, South Holland, Netherlands

Erasmus University Medical Center

Rotterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06756542


Related Trials